Latest news for Ludwig Enterprises (OTC:LUDG) Stock

Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.

LUDWIG ENTERPRISES by Ludwig Enterprises, Inc.

Ludwig Enterprises Inc

News

Press Releases

Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study

Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer

Ludwig Announces Substantial Corporate Initiatives

Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)

Ludwig Announces Acquisition of Intellectual Property and Patent

Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

Comments

Ludwig Enterprises

News

Latest news for Ludwig Enterprises (OTC:LUDG) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga